Tenet Healthcare (THC) Tops Q4 EPS by 112c ; Offers Guidance

Tenet Healthcare (NYSE: THC) reported Q4 EPS of $2.68, $1.12 better than the analyst estimate of $1.56. Revenue for the quarter came in at $5.38 billion versus the consensus estimate of $5.27 billion.

GUIDANCE:

Tenet Healthcare sees Q1 2024 EPS of $1.24-$1.62, versus the consensus of $1.35. Tenet Healthcare sees Q1 2024 revenue of $5-5.2 billion, versus the consensus of $5.26 billion.

Tenet Healthcare sees FY2024 EPS of $5.76-$6.90, versus the consensus of $5.84. Tenet Healthcare sees FY2024 revenue of $19.9-20.3 billion, versus the consensus of $21.3 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Tenet to Report Its Second Quarter 2026 Results on July 24
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge